CMC Comparability Protocols Should Specify Tests, Analytical Procedures
This article was originally published in The Tan Sheet
Executive Summary
Companies should include a list of tests and studies they expect to conduct on drug products in their chemistry, manufacturing and controls comparability protocols, an FDA draft guidance suggests